AI 128
Alternative Names: AI-SRLatest Information Update: 16 Jul 2016
At a glance
- Originator Acusphere
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Asthma in Europe (Inhalation, Powder)
- 09 Aug 2006 AI 128 is still available for partnering worldwide (http://www.acusphere.com)
- 22 Jun 2005 AI 128 is available for partnering worldwide (http://www.acusphere.com)